Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan.

The Southeast Asian journal of tropical medicine and public health - 1 Jan 1999

Chiang S H, Wu S J, Wu K F, Hsiao K J

Abstract excerpt

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathic disease in Taiwan. The mass neonatal screening of G6PD deficiency by fluorometric spot test in Taiwan was started with a pilot program in 1984. The nationwide screening was started on July 1, 1987, and a follow-up system comprising of eighteen referral hospitals, including outlying islands, was organized for confirmatory test,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glucosephosphate Dehydrogenase
Share to Glucosephosphate Dehydrogenase Deficiency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant, Newborn

Share to Mutation

Share to Neonatal Screening

Share to Quality Assurance, Health Care

Share to Referral and Consultation

Share to Taiwan

Source

Identifiers

PMID: 11400791

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan.PMID 11400791Read ↗

Incidence and molecular characterization of Glucose-6-Phosphate Dehydrogenase deficiency among neonates for newborn screening in Chaozhou, China.Semantic proximity Read ↗

Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017Semantic proximity Read ↗

Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience.Semantic proximity Read ↗

Mutation of glucose-6-phosphate dehydrogenase deficiency in Chinese Han children in eastern Fujian.Semantic proximity Read ↗

Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates.Semantic proximity Read ↗

[Correlation analysis of genotypes and the enzymatic activities of glucose-6-phosphate dehydrogenase in neonates in Guangzhou].Semantic proximity Read ↗

Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infantsSemantic proximity Read ↗

[Screening results and genetic features of glucose-6-phosphate dehydrogenase deficiency in 54 025 preterm infants in Chengdu, China].Semantic proximity Read ↗

Screening, genotyping and haematological analysis of glucose-6-phosphate dehydrogenase deficiency in the blood donors of Wuxi City, China.Semantic proximity Read ↗

Rapid detection of twenty-nine common Chinese glucose-6-phosphate dehydrogenase variants using a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay on dried blood spots.Semantic proximity Read ↗

Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort studySemantic proximity Read ↗

Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: five mutations account for most G6PD deficiency cases in Taiwan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.